Study on the individualized medication of regorafenib in patients with colorectal cancer

ABSTRACT: Interventions: Case series:None Primary outcome(s): dosage Study Design: Sequential

DISEASE(S): Colorectal Cancer

PROVIDER: 2761757 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR